Literature DB >> 9181657

Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.

M Hirose1, Y Hidaka, C Miyazaki, K Ueda, H Yoshikawa.   

Abstract

We report 5 patients with secondary vaccine failure (SVF) who were infected with natural measles 2, 5, 5, 7 and 12 years, respectively, after vaccination with further attenuated live measles vaccine during infancy. Their seroconversion had been confirmed after vaccination. Three of the 5 patients had mild (modified) measles, while the remaining 2 patients had typical measles. The hemagglutination inhibition antibody titers to measles virus in paired acute and convalescent sera showed a secondary response pattern in 4/5 patients, and a primary response pattern was present in the remaining patient. Measles IgM antibodies were present in all patients during the convalescent stage. The patient with the primary response pattern may have had a decrease in the B cell memory during the 5-year period between vaccination and infection. This may be the first SVF case report that confirms the existence of completely waning immunity in recipients of the further attenuated live measles vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9181657     DOI: 10.3109/00365549709035882

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

Review 1.  Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.

Authors:  Paolo Bonanni; Anne Gershon; Michael Gershon; Andrea Kulcsár; Vassiliki Papaevangelou; Bernard Rentier; Catherine Sadzot-Delvaux; Vytautas Usonis; Timo Vesikari; Catherine Weil-Olivier; Peter de Winter; Peter Wutzler
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

2.  [Elimination of measles in the WHO European Region-challenges persist].

Authors:  Mark Muscat; Myriam Ben Mamou; Simarjit Singh; Catharina de Kat; Dragan Jankovic; Shahin Huseynov; Sergei Deshevoi; Siddhartha Datta; Patrick O'Connor
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

3.  The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Amabelia Rodrigues; Christine S Benn; Hilton Whittle
Journal:  BMJ Open       Date:  2012-07-19       Impact factor: 2.692

4.  Measles vaccine coverage and factors related to uncompleted vaccination among 18-month-old and 36-month-old children in Kyoto, Japan.

Authors:  Takayo Matsumura; Takeo Nakayama; Shigeru Okamoto; Hideko Ito
Journal:  BMC Public Health       Date:  2005-06-04       Impact factor: 3.295

5.  Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.

Authors:  Raed Ibrahim Altulayhi; Rakan M Alqahtani; Reem Abdullah Alakeel; Faten Abdulrahman Khorshid; Rehab Hamoud Alshammari; Sana Ghazi Alattas; Fahad Abdullah M Alshammari; May Bin-Jumah; Mohamed M Abdel-Daim; Mohammad Almohideb
Journal:  Environ Sci Pollut Res Int       Date:  2021-06-29       Impact factor: 5.190

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.